European heart journal
Journal
Overview
publication venue for
-
Non-invasive FFRCT revealing severe inducible ischaemia in an anomalous right coronary artery.
2017
-
An unusual case of right-sided heart failure caused by giant sinus of Valsalva aneurysm obstructing right ventricular outflow tract.
2014
-
Posterior left pericardiotomy in cardiac surgery and outcomes: PALACS-EF trial extended follow-up.
2025
-
The SWEDEGRAFT trial: when absence of evidence is not evidence of absence..
46.
2025
-
Deep learning for echocardiographic assessment and risk stratification of aortic, mitral, and tricuspid regurgitation: the DELINEATE-Regurgitation study.
2025
-
Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial..
45.
2024
-
Percutaneous vs. surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease: the SWEDEHEART registry.
2024
-
Beyond the classic major cardiovascular event outcome for cardiovascular trials..
45.
2024
-
Great debate: myocardial infarction after cardiac surgery must be redefined..
45.
2024
-
Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial..
45.
2024
-
Transcatheter heart valve explant with infective endocarditis-associated prosthesis failure and outcomes: the EXPLANT-TAVR international registry.
2024
-
Coronary angiography and bypass surgery: born together and now going separate ways?.
45.
2024
-
Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trial..
44.
2023
-
Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints..
44.
2023
-
2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG..
44.
2023
-
A2AR-mediated lymphangiogenesis via VEGFR2 signaling prevents salt-sensitive hypertension..
44.
2023
-
Radial artery vs. internal thoracic artery or saphenous vein grafts: 15-year results of the RAPCO trials..
44.
2023
-
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance..
44.
2023
-
Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients..
44.
2023
-
Iron Deficiency in Pulmonary Vascular Disease: Pathophysiological and Clinical Implications.
2023
-
Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial..
44.
2023
-
Single versus multiple arterial grafting in diabetic patients at 10 years: the Arterial Revascularization Trial..
43.
2022
-
Post-operative atrial fibrillation and risk of heart failure hospitalization..
43.
2022
-
Left main revascularization: an evidence-based reconciliation..
43.
2022
-
Lung function impairment and risk of incident heart failure: the NHLBI Pooled Cohorts Study..
43.
2022
-
Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial..
43.
2022
-
Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease..
43.
2022
-
Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study..
43.
2022
-
Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data..
43.
2021
-
Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study..
42.
2021
-
Telomerase therapy reverses vascular senescence and extends lifespan in progeria mice..
42.
2021
-
Retractions in medicine: the tip of the iceberg..
42.
2021
-
Mammographic features are associated with cardiometabolic disease risk and mortality..
42.
2021
-
Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)..
42.
2021
-
Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI)..
42.
2021
-
Taking a stand against air pollution - the impact on cardiovascular disease..
42.
2021
-
The association between coronary graft patency and clinical status in patients with coronary artery disease..
42.
2021
-
The win ratio approach for composite endpoints: practical guidance based on previous experience..
41.
2020
-
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial..
41.
2020
-
Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis..
41.
2020
-
Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries..
41.
2020
-
Low and elevated B-type natriuretic peptide levels are associated with increased mortality in patients with preserved ejection fraction undergoing transcatheter aortic valve replacement: an analysis of the PARTNER II trial and registry..
41.
2020
-
Machine learning of clinical variables and coronary artery calcium scoring for the prediction of obstructive coronary artery disease on coronary computed tomography angiography: analysis from the CONFIRM registry..
41.
2020
-
Sex-based differences in outcomes, 30-day readmissions, and costs following catheter ablation of atrial fibrillation: the United States Nationwide Readmissions Database 2010-14..
40.
2019
-
Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index..
40.
2019
-
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial..
40.
2019
-
Impact of preoperative fractional flow reserve on arterial bypass graft anastomotic function: the IMPAG trial..
40.
2019
-
New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trial..
40.
2019
-
Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial..
40.
2019
-
Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add?.
40.
2019
-
Pretreatment with P2Y12 receptor antagonists in ST-elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry..
40.
2019
-
Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification..
40.
2019
-
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial..
39.
2018
-
An update on the journey towards precision medicine in cardiology..
39.
2018
-
Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study..
39.
2018
-
Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial..
39.
2018
-
SCN5A mutations in 442 neonates and children: genotype-phenotype correlation and identification of higher-risk subgroups..
39.
2018
-
The heart regulates the endocrine response to heart failure: cardiac contribution to circulating neprilysin..
39.
2018
-
Staging classification of aortic stenosis based on the extent of cardiac damage..
38.
2017
-
BDNFVal66met polymorphism: a potential bridge between depression and thrombosis..
38.
2017
-
Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial..
38.
2017
-
The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX..
37.
2015
-
Current worldwide nuclear cardiology practices and radiation exposure: results from the 65 country IAEA Nuclear Cardiology Protocols Cross-Sectional Study (INCAPS)..
36.
2015
-
Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction..
36.
2015
-
Sustainable Development Goals and the future of cardiovascular health. A statement from the Global Cardiovascular Disease Taskforce..
35.
2014
-
Establishing reference values for central blood pressure and its amplification in a general healthy population and according to cardiovascular risk factors..
35.
2014
-
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial..
35.
2014
-
Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial..
35.
2014
-
Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation..
35.
2014
-
High proportion of patients with end-stage heart failure regardless of aetiology demonstrates anti-cardiac antibody deposition in failing myocardium: humoral activation, a potential contributor of disease progression..
35.
2013
-
Cardiologists urged to reduce inappropriate radiation exposure..
34.
2013
-
Hypertensive target organ damage predicts incident diabetes mellitus..
34.
2013
-
Lack of protective role of HDL-C in patients with coronary artery disease undergoing elective coronary artery bypass grafting..
34.
2013
-
Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA·CER) trial..
34.
2013
-
Phosphate: a novel cardiovascular risk factor..
34.
2012
-
Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit..
33.
2012
-
Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke)..
33.
2012
-
The impact of height on the risk of atrial fibrillation: the Cardiovascular Health Study..
33.
2012
-
Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea..
33.
2012
-
Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes..
33.
2012
-
High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial..
33.
2011
-
Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial..
32.
2011
-
Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes..
32.
2011
-
All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy..
31.
2010
-
Towards a new order in cardiovascular medicine: re-engineering through global collaboration..
31.
2010
-
QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study..
30.
2009
-
Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes..
30.
2009
-
Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy..
29.
2008
-
Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure..
29.
2008
-
Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study..
29.
2008
-
Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study..
28.
2007
-
Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials..
26.
2004
-
Left ventricular concentric geometry is associated with impaired relaxation in hypertension: the HyperGEN study..
26.
2004
-
Survival after aortic valve replacement for aortic stenosis: does left ventricular mass regression have a clinical correlate?.
26.
2004
-
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes..
25.
2004
-
Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission?.
24.
2003
-
Predictors of 90-day outcome in patients stabilized after acute coronary syndromes..
24.
2003
-
Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction? Insights from the PURSUIT Trial..
23.
2002
-
Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker..
23.
2002
-
Application of the National Cholesterol Education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)..
21.
2000
-
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT..
21.
2000
-
Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database study..
20.
1999
-
Platelet alpha 2 adrenoceptor characteristics during the morning increase in platelet aggregability..
13.
1992
-
Adrenergic nervous system and left ventricular mass in primary hypertension..
10.
1989
-
Beneficial effects of diltiazem combined with beta blockade in angina pectoris..
6.
1985
-
Beneficial effect of adding nifedipine to beta-adrenergic blocking therapy in angina pectoris..
3.
1982
-
Beneficial effect of enhanced myocardial carbohydrate utilisation after oxfenicine (L-hydroxyphenylglycine) in angina pectoris..
1.
1980
-
Quality versus Quantity in Cardiothoracic Imaging: Limitations of the Relative Value Unit (RVU)..
40.
2019
-
Relationship between blood pressure and blood viscosity..
14.
1993
-
Circadian influences, time of hospitalization, and prognosis in acute myocardial infarction.
2019
-
A double blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days.
2007
-
Intra-operative and post-operative management of conduits for coronary artery bypass grafting: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Surgery and the European Association for Cardio-Thoracic Surgery Coronary Task Force.
2025
-
Embolic strokes of undetermined source: a clinical consensus statement of the ESC Council on Stroke, the European Association of Cardiovascular Imaging and the European Heart Rhythm Association of the ESC.
2024
-
Left main revascularization: breaking through the sounds of silence..
43.
2022
-
The conundrum of the treatment for left main coronary disease..
41.
2020
-
Cancer cachexia: getting to the heart of the matter..
40.
2019
-
High resting heart rate predicts mortality, disability, and cognitive decline in patients after ischaemic stroke: time for additional selective I(f) channel inhibitor trials?.
33.
2012
-
Road mapping ATLAS ACS 2: are we there yet?.
33.
2012
-
Tissue Doppler imaging for the pre-clinical diagnosis of cardiomyopathy..
25.
2004
-
Early invasive strategy for acute coronary syndromes without persistent ST-segment elevation: has the time come for 'drive-through' angiography?.
23.
2002
-
What have we learned from the recent large trials in acute coronary syndromes without ST-segment elevation?.
21.
2000
-
Improved outlook for patients with acute myocardial infarction: an interim progress report..
19.
1998
-
Progress in exercise electrocardiography..
17.
1996
-
Clinical applications of machine learning in cardiovascular disease and its relevance to cardiac imaging.
2019
-
Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval.
2007
-
Arterial conduits for coronary bypass grafting: the set-point concept.
2025
-
ESC/EACTS vs. ACC/AHA guidelines for the management of severe aortic stenosis.
2023
-
Left main coronary disease: evolving management concepts.
2022
-
Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials.
2021
-
Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials.
2020
-
Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis.
2020
-
Validation of non-invasive central blood pressure devices: ARTERY Society task force consensus statement on protocol standardization.
2017
-
Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized trials.
2017
-
The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement?
2015
-
Central blood pressure: current evidence and clinical importance.
2014
-
Review of surgical prosthetic paravalvular leaks: diagnosis and catheter-based closure.
2012
-
Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes.
2007
-
Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials.
2007
-
Outcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes.
2006
-
Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy.
2002
-
Description of patients undergoing high risk angioplasty. Analyses of various databases.
1995
-
Early clinical experience with integrelin, an inhibitor of the platelet glycoprotein IIb/IIIa integrin receptor.
1995
-
Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease.
1993
-
Measurement of cardiac output by M-mode and two-dimensional echocardiography: application to patients with hypertension.
1990
-
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
2006
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)